BJUI compass
Five-year outcomes of TOOKAD® (WST-11) vascular-targeted photodynamic therapy for low-risk prostate cancer patients: Insights from a tertiary referral centre.
Andrea Cosenza, Francesco Barletta, Leonardo Quarta, Michele Brancaccio, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti, Armando Stabile
Published: 202510.1002/bco2.70106
No abstract available for this study.